Volatile applications against pathogens

US2016374344A9 · US · A9

Patent metadata
FieldValue
Publication numberUS-2016374344-A9
Application numberUS-201514690929-A
CountryUS
Kind codeA9
Filing dateApr 20, 2015
Priority dateJan 30, 2013
Publication dateDec 29, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This invention is related to the use of a volatile antimicrobial compound against pathogens affecting humans comprising contacting infected areas with an atmosphere containing an effective amount of a volatile antimicrobial compound in gaseous form. The volatile antimicrobial compounds provided include certain oxaborole compounds, for example benzoxaboroles. Delivery systems are provided to take advantage of the volatile nature of these antimicrobial compounds. The method and use disclosed can be combined with other volatile compounds.

First claim

Opening claim text (preview).

We claim: 1 . A method of using a volatile antimicrobial compound against pathogens, comprising: contacting areas infected by the pathogens with an atmosphere containing an effective amount of the volatile antimicrobial compound in gaseous form, the volatile antimicrobial compound having a structure of formula (VI): wherein each R is independently hydrogen, alkyl, alkene, alkyne, haloalkyl, haloalkene, haloalkyne, alkoxy, alkeneoxy, haloalkoxy, aryl, heteroaryl, arylalkyl, arylalkene, arylalkyne, heteroarylalkyl, heteroarylalkene, heteroarylalkyne, halogen, hydroxyl, nitrile, amine, ester, carboxylic acid, ketone, alcohol, sulfide, sulfoxide, sulfone, sulfoximine, sulfilimine, sulfonamide, sulfate, sulfonate, nitroalkyl, amide, oxime, imine, hydroxylamine, hydrazine, hydrazone, carbamate, thiocarbamate, urea, thiourea, carbonate, aryloxy, or heteroaryloxy; n=1, 2, 3, or 4; B is boron; X═(CR 2 ) m where m=1, 2, 3, or 4; Y is alkyl, alkene, alkyne, haloalkyl, haloalkene, haloalkyne, alkoxy, alkeneoxy, haloalkoxy, aryl, heteroaryl, arylalkyl, arylalkene, arylalkyne, heteroarylalkyl, heteroarylalkene, heteroarylalkyne, hydroxyl, nitrile, amine, ester, carboxylic acid, ketone, alcohol, sulfide, sulfoxide, sulfone, sulfoximine, sulfilimine, sulfonamide, sulfate, sulfonate, nitroalkyl, amide, oxime, imine, hydroxylamine, hydrazine, hydrazone, carbamate, thiocarbamate, urea, thiourea, carbonate, aryloxy, or heteroaryloxy; with a proviso that R is not aryloxy or heteroaryloxy when Y is hydroxyl; and pharmaceutically or agriculturally acceptable salts thereof. 2 . The method of claim 1 , wherein the areas affected by the pathogens are selected from the group consisting of vaginal yeast infections, athlete's foot, tinea, or combinations thereof. 3 . The method of claim 1 , wherein the pathogens are selected from the group consisting of Candida albicans, C. tropicalis, C. glabrata, C. krusei, C. parapsilosis, C. dubliniensis, C. lusitaniae, Epidermophyton flocoosum, Trichiphyton rubrum, Trichophyton mentagrophytes , or combinations thereof. 4 . The method of claim 1 , further comprising impregnating, microencapsulating, or coating a material for releasing the volatile antimicrobial compound in a gaseous form. 5 . The method of claim 1 , wherein the volatile antimicrobial compound remain in its gaseous form for seven days. 6 . The method of claim 1 , wherein the volatile antimicrobial compound has a structure of 7 . A method of using a volatile antimicrobial compound against pathogens, comprising: (a) mixing a volatile antimicrobial compound with an organic solvent; (b) heating the mixture from step (a) to evaporate the organic solvent and render the volatile antimicrobial compound into its gaseous form; and (c) contacting areas infected by the pathogens with an atmosphere containing an effective amount of the volatile antimicrobial compound in gaseous form at a temperature between 1° C. and 50° C.; wherein the volatile antimicrobial compound having a structure of formula (IV): each R is independently hydrogen, alkyl, alkene, alkyne, haloalkyl, haloalkene, haloalkyne, alkoxy, alkeneoxy, haloalkoxy, aryl, heteroaryl, arylalkyl, arylalkene, arylalkyne, heteroarylalkyl, heteroarylalkene, heteroarylalkyne, halogen, hydroxyl, nitrile, amine, ester, carboxylic acid, ketone, alcohol, sulfide, sulfoxide, sulfone, sulfoximine, sulfilimine, sulfonamide, sulfate, sulfonate, nitroalkyl, amide, oxime, imine, hydroxylamine, hydrazine, hydrazone, carbamate, thiocarbamate, urea, thiourea, carbonate, aryloxy, or heteroaryloxy; n=1, 2, 3, or 4; B is boron; X═(CR 2 ) m where m=1, 2, 3, or 4; Y is alkyl, alkene, alkyne, haloalkyl, haloalkene, haloalkyne, alkoxy, alkeneoxy, haloalkoxy, aryl, heteroaryl, arylalkyl, arylalkene, arylalkyne, heteroarylalkyl, heteroarylalkene, heteroarylalkyne, hydroxyl, nitrile, amine, ester, carboxylic acid, ketone, alcohol, sulfide, sulfoxide, sulfone, sulfoximine, sulfilimine, sulfonamide, sulfate, sulfonate, nitroalkyl, amide, oxime, imine, hydroxylamine, hydrazine, hydrazone, carbamate, thiocarbamate, urea, thiourea, carbonate, aryloxy, or heteroaryloxy; with a proviso that R is not aryloxy or heteroaryloxy when Y is hydroxyl; and pharmaceutically or agriculturally acceptable salts thereof. 8 . The method of claim 7 , wherein the areas affected by the pathogens are selected from the group consisting of vaginal yeast infections, athlete's foot, tinea, or combinations thereof. 9 . The method of claim 7 , wherein the pathogens are selected from the group consisting of Candida albicans, C. tropicalis, C. glabrata, C. krusei, C. parapsilosis, C. dubliniensis, C. lusitaniae, Epidermophyton flocoosum, Trichiphyton rubrum, Trichophyton mentagrophytes , or combinations thereof. 10 . The method of claim 7 , wherein the volatile antimicrobial compound remain in its gaseous form for seven days. 11 . The method of claim 7 , wherein the volatile antimicrobial compound has a structure of 12 . The method of claim 7 , wherein the organic solvent comprise acetone or ethanol. 13 . A method of using a volatile antimicrobial compound against pathogens, comprising: contacting areas infected by the pathogens with an atmosphere containing an effective amount of the volatile antimicrobial compound in gaseous form, the volatile antimicrobial compound having a structure of formula (A1) or (A2): wherein each of A 1 , A 2 , D 1 , and D 2 is independently hydrogen, substituted or unsubstituted C 1-18 -alkyl, arylalkyl, aryl, or heterocyclic; or A 1 and D 1 , or A 2 and D 2 together form a 5, 6, or 7-membered fused ring which is substituted or unsubstituted; each of R 13 , R 16 , R 17 , R 18 , and R 19 is independently hydrogen, substituted or unsubstituted C 1-6 -alkyl, nitrile, nitro, aryl or aryl alkyl; or R 16 and R 17 , or R 18 and R 19 together form an alicyclic ring which is substituted or unsubstituted; B is boron; G is a substituted or unsubstituted C 1-18 -alkylene, arylalkylene, arylene, or heterocyclic moiety; and pharmaceutically or agriculturally acceptable salts thereof. 14 . The method of claim 13 , wherein the areas affected by the pathogens are selected from the group consisting of vaginal yeast infections, athlete's foot, tinea, or combinations thereof. 15 . The method of claim 13 , wherein the pathogens are selected from the group consisting of Candida albicans, C. tropicalis, C. glabrata, C. krusei, C. parapsilosis, C. dubliniensis, C. lusitaniae, Epidermophyton flocoosum, Trichiphyton rubrum, Trichophyton mentagrophytes , or combinations thereof. 16 . The method of claim 13 , further comprising impregnating, microencapsulating, or coating a material for releasing the volatile antimicrobial compound in a gaseous form. 17 . The method of claim 13 , wherein the volatile antimicrobial compound remain in its gaseous form for seven days. 18 .

Assignees

Inventors

Classifications

  • Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur (containing organo-phosphorus compounds A01N57/00) · CPC title

  • in the form of gases, e.g. fumigation; Compositions or apparatus therefor · CPC title

  • in a controlled atmosphere comprising other gases in addition to CO2, N2, O2 or H2O {; Elimination of such other gases} · CPC title

  • Organic compounds; Microorganisms; Enzymes · CPC title

  • Boron compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016374344A9 cover?
This invention is related to the use of a volatile antimicrobial compound against pathogens affecting humans comprising contacting infected areas with an atmosphere containing an effective amount of a volatile antimicrobial compound in gaseous form. The volatile antimicrobial compounds provided include certain oxaborole compounds, for example benzoxaboroles. Delivery systems are provided to tak…
Who is the assignee on this patent?
Agrofresh Inc
What technology area does this patent fall under?
Primary CPC classification A01N55/08. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Dec 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A9). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).